These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Isoniazid therapy for latent tuberculosis in psoriasis patients receiving biological agents: is it safe and efficacious? Sánchez-Moya AI; Dauden E Int J Dermatol; 2014 Mar; 53(3):e211-2. PubMed ID: 23786208 [No Abstract] [Full Text] [Related]
15. Update on cost-effectiveness of a 12-dose regimen for latent tuberculous infection at new rifapentine prices. Shepardson D; MacKenzie WR Int J Tuberc Lung Dis; 2014 Jun; 18(6):751. PubMed ID: 24903950 [No Abstract] [Full Text] [Related]
16. Question 1: what are the options for treating latent TB infection in children? Gwee A; Coghlan B; Curtis N Arch Dis Child; 2013 Jun; 98(6):468-74. PubMed ID: 23661667 [No Abstract] [Full Text] [Related]
17. Treatment of latent tuberculosis infection induces changes in multifunctional Mycobacterium tuberculosis-specific CD4+ T cells. Sauzullo I; Mengoni F; Mascia C; Rossi R; Lichtner M; Vullo V; Mastroianni CM Med Microbiol Immunol; 2016 Feb; 205(1):37-45. PubMed ID: 26108901 [TBL] [Abstract][Full Text] [Related]
18. Tuberculosis preventive chemotherapy: the times they are a-changin'. Dedicoat M; Lange C Int J Tuberc Lung Dis; 2015 Sep; 19(9):1002. PubMed ID: 26260815 [No Abstract] [Full Text] [Related]
19. Treatment of Latent Tuberculosis Infection. Haley CA Microbiol Spectr; 2017 Apr; 5(2):. PubMed ID: 28409555 [TBL] [Abstract][Full Text] [Related]
20. New approaches to the treatment of latent tuberculosis. Sterling TR Semin Respir Crit Care Med; 2008 Oct; 29(5):532-41. PubMed ID: 18810686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]